CV
Cadrenal Therapeutics, Inc. Common Stock
CVKD · NASDAQ
$1.19 -2.46% (-$0.03)
1M -38.66%
Market Cap $4.25M
P/E Ratio -
Div. Yield -
ROE 406.38%
Piotroski F-Score Weak
2/9Valuation
100 /100
Cheap P/B 1.04x
EV/EBITDA N/A
P/S N/A
Growth
-
N/A Rev. growth N/A
FCF growth N/A
Book val. growth N/A
Profitability
-
N/A Net margin N/A
Op. margin N/A
FCF margin N/A
Quality
0 /100
Poor ROE 406.38%
ROA 206.55%
Asset turnover 0.00x
Debt
100 /100
Low Current ratio 3.73x
Debt/Equity 0.00x
Net debt/EBITDA N/A
Stability
42 /100
Moderate EPS volatility 17.65%
Profitable years 0
Beta 1.84x
Bulios Scoring descrie calitatea și istoricul unei companii, nu randamentul viitor. Un scor ridicat nu este un semnal de cumpărare. Află mai multe
Întreabă StockBot despre CVKD
Online
Sector
Healthcare
Industry
Biotechnology
CEO
Quang X. Pham
Employees
5
Headquarters
Ponte Vedra
Evenimente viitoare
09 NOV.
Earnings
Upcoming earnings report